Johnson & Johnson COVID-19 Vaccine Update

GVHC Pauses Johnson and johnson covid-19 vaccine distribution

April 13th, 2021 – Due to recent guidance from the CDC and the FDA GVHC will be pausing the distribution of the Johnson and Johnson COVID-19 Vaccine.

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the US. The CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J& J vaccine.

Right now, these adverse events appear to be extremely rare. Patient safety is our top priority at Golden Valley Health Centers which is why we are pausing any further J& J vaccinations for now.  GVHC will continue to offer both the Moderna and Pfizer vaccine at many of our locations.

If you have received the Johnson & Johnson vaccine and have not had any side effects associated with blood clots, officials say the risk of having a reaction is unlikely.

Common temporary reactions after receiving the COVID-19 vaccine include sore arm, headache, tiredness, and fever. Some people experience lightheadedness and nausea.

The CDC recommends the following measures to prevent adverse effects:

  • Staying hydrated and having a snack before the appointment
  • Taking slow, deep breaths and focusing on something relaxing before getting the vaccine
  • Sitting or lying down after being vaccinated

People who have received the J& J vaccine and develop severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact us by calling or texting 1-866-682-4842 to schedule an appointment with their primary care provider.